Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6691)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 27, 2021 (publication date) through Nov 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ortiz GX, Lenhart G, Becker MW, Schwambach KH, Tovo CV, Blatt CR. Drug-induced liver injury and COVID-19: A review for clinical practice. World J Hepatol 2021; 13(9): 1143-1153 [PMID: 34630881 DOI: 10.4254/wjh.v13.i9.1143] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i9/1143.htm |
| Number | Citing Articles |
| 1 |
Effie Polyzogopoulou, Pinelopi Amoiridou, Theodore P Abraham, Ioannis Ventoulis. Acute liver injury in COVID-19 patients hospitalized in the intensive care unit: Narrative review. World Journal of Gastroenterology 2022; 28(47): 6662-6688 doi: 10.3748/wjg.v28.i47.6662
|
| 2 |
Nimy John, Brittney Ibrahim, Mark Ebaid, Sammy Saab. Outcomes in Patients with Liver Dysfunction Post SARS-CoV-2 Infection: What Should We Measure?. Hepatic Medicine: Evidence and Research 2023; : 185 doi: 10.2147/HMER.S371507
|
| 3 |
Zsófia Gáspár, Bálint Gergely Szabó, Noémi Kiss-Dala, János Szlávik, István Vályi-Nagy, Botond Lakatos. A COVID–19-hez kapcsolódó májenzim-emelkedés valószínűleg multifaktoriális eredetű. Orvosi Hetilap 2022; 163(36): 1415 doi: 10.1556/650.2022.32590
|
| 4 |
Ioanna Papagiouvanni, Serafeim-Chrysovalantis Kotoulas, Athanasia Pataka, Dionisios G Spyratos, Konstantinos Porpodis, Afroditi K Boutou, Georgios Papagiouvannis, Ioanna Grigoriou, Christos Vettas, Ioannis Goulis. COVID-19 and liver injury: An ongoing challenge. World Journal of Gastroenterology 2023; 29(2): 257-271 doi: 10.3748/wjg.v29.i2.257
|
| 5 |
Hedy A. Badary, Mohamed B. Hashem, Mohamed El-Kassas. Drug-induced liver injury during the era of COVID-19 polypharmacy: a statement of account, lessons learned, and a proposed approach. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00381-0
|
| 6 |
Gabriel Moreira de M Mendes, Israel Júnior Borges Do Nascimento, Paulo HS. Marazzi-Diniz, Izabela B. Da Silveira, Matheus F. Itaborahy, Luiz E. Viana, Filipe A. Silva, Monique F Santana, Rebecca AA. Pinto, Bruna G. Dutra, Marcus Vinicius G. Lacerda, Stanley A. Araujo, David Wanderley, Paula VT. Vidigal, Paulo HC Diniz, Thiago Verano-Braga, Robson AS. Santos, M Fatima Leite. The des-Arg9-bradykinin/B1R axis: Hepatic damage in COVID-19. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.1080837
|
| 7 |
Rolf Teschke, Axel Eickhoff. Features, Transmission, Detection, and Case Studies in COVID-19. 2024; : 267 doi: 10.1016/B978-0-323-95646-8.00047-0
|
| 8 |
Jingjing Huang, Zhaokang Zhang, Chenxia Hao, Yuzhen Qiu, Ruoming Tan, Jialin Liu, Xiaoli Wang, Wanhua Yang, Hongping Qu. Identifying Drug-Induced Liver Injury Associated With Inflammation-Drug and Drug-Drug Interactions in Pharmacologic Treatments for COVID-19 by Bioinformatics and System Biology Analyses: The Role of Pregnane X Receptor. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.804189
|
| 9 |
Nicolò Brandi, Daniele Spinelli, Alessandro Granito, Francesco Tovoli, Fabio Piscaglia, Rita Golfieri, Matteo Renzulli. COVID-19: Has the Liver Been Spared?. International Journal of Molecular Sciences 2023; 24(2): 1091 doi: 10.3390/ijms24021091
|
| 10 |
Fares E M Ali, Mostafa K Abd El-Aziz, Mahmoud M Ali, Osama M Ghogar, Adel G Bakr. COVID-19 and hepatic injury: cellular and molecular mechanisms in diverse liver cells. World Journal of Gastroenterology 2023; 29(3): 425-449 doi: 10.3748/wjg.v29.i3.425
|
| 11 |
Hideo Yamasaki, Hideyuki Imai, Atsuko Tanaka, Joji M. Otaki. Pleiotropic Functions of Nitric Oxide Produced by Ascorbate for the Prevention and Mitigation of COVID-19: A Revaluation of Pauling’s Vitamin C Therapy. Microorganisms 2023; 11(2): 397 doi: 10.3390/microorganisms11020397
|
| 12 |
Juan Carlos Restrepo-Gutiérrez, Ana Isabel Toro-Montoya. Enfermedad hepatobiliar asociada a COVID-19. Hepatología 2022; : 143 doi: 10.52784/27112330.155
|
| 13 |
Lekha Saha, Soumya Vij, Kajal Rawat. Liver injury induced by COVID 19 treatment – what do we know?. World Journal of Gastroenterology 2022; 28(45): 6314-6327 doi: 10.3748/wjg.v28.i45.6314
|
| 14 |
Cristina Maria Marginean, Eliza Cinteza, Corina Maria Vasile, Mihaela Popescu, Viorel Biciusca, Anca Oana Docea, Radu Mitrut, Marian Sorin Popescu, Paul Mitrut. Features of Liver Injury in COVID-19 Pathophysiological, Biological and Clinical Particularities. Gastroenterology Insights 2023; 14(2): 156 doi: 10.3390/gastroent14020012
|
| 15 |
Samar A. Antar, Nada A. Ashour, Amir O. Hamouda, Ayman M. Noreddin, Ahmed A. Al‐Karmalawy. Recent advances in COVID-19-induced liver injury: causes, diagnosis, and management. Inflammopharmacology 2024; 32(5): 2649 doi: 10.1007/s10787-024-01535-7
|
| 16 |
Gabriela Xavier Ortiz, Ana Helena Dias Pereira dos Santos Ulbrich, Gabriele Lenhart, Henrique Dias Pereira dos Santos, Karin Hepp Schwambach, Matheus William Becker, Carine Raquel Blatt. Drug-induced liver injury and COVID-19: Use of artificial intelligence and the updated Roussel Uclaf Causality Assessment Method in clinical practice. Artificial Intelligence in Gastroenterology 2023; 4(2): 36-47 doi: 10.35712/aig.v4.i2.36
Abstract(436) |
Core Tip(485) |
Full Article(HTML)(1339)
|
Full Article with Cover (PDF)-816K(78)
|
Full Article (Word)-222K(39)
|
Audio-121K(19)
|
Peer-Review Report-242K(53)
|
Answering Reviewers-422K(55)
|
Full Article (PDF)-561K(79)
|
Full Article (XML)-144K(56)
|
Times Cited (0)
|
Total Visits (5174)
|
Open
|
| 17 |
M.E. Zharova, I.O. Ivanikov, Yu.V. Grigorieva, E.L. Nikonov. Liver injury in COVID-19: clinical features and risk factors. Dokazatel'naya gastroenterologiya 2023; 12(3): 51 doi: 10.17116/dokgastro20231203151
|
| 18 |
Jenifer Mallavarpu Ambrose, Malathi Kullappan, Shankargouda Patil, Khalid J. Alzahrani, Hamsa Jameel Banjer, Fadi S. I. Qashqari, A. Thirumal Raj, Shilpa Bhandi, Vishnu Priya Veeraraghavan, Selvaraj Jayaraman, Durairaj Sekar, Alok Agarwal, Korla Swapnavahini, Surapaneni Krishna Mohan. Plant-Derived Antiviral Compounds as Potential Entry Inhibitors against Spike Protein of SARS-CoV-2 Wild-Type and Delta Variant: An Integrative in SilicoApproach. Molecules 2022; 27(6): 1773 doi: 10.3390/molecules27061773
|
| 19 |
Rolf Teschke, Nahum Méndez-Sánchez, Axel Eickhoff. Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method. International Journal of Molecular Sciences 2022; 23(9): 4828 doi: 10.3390/ijms23094828
|
| 20 |
Ravi Gandham, Madhavi Eerike, Gerard M. Raj, Debasis Bisoi, Rekha Priyadarshini, Neeraj Agarwal. Adverse events following remdesivir administration in moderately ill COVID-19 patients - A retrospective analysis. Journal of Family Medicine and Primary Care 2022; 11(7): 3693 doi: 10.4103/jfmpc.jfmpc_2468_21
|
| 21 |
Eleni Karlafti, Daniel Paramythiotis, Konstantina Pantazi, Vasiliki Epameinondas Georgakopoulou, Georgia Kaiafa, Petros Papalexis, Adonis A. Protopapas, Eleftheria Ztriva, Varvara Fyntanidou, Christos Savopoulos. Drug-Induced Liver Injury in Hospitalized Patients during SARS-CoV-2 Infection. Medicina 2022; 58(12): 1848 doi: 10.3390/medicina58121848
|
| 22 |
V. I. Petrov, A. Yu. Ryazanova, N. S. Tokareva. Analysis of the Consumption of Medicinal Products Associated with a High Risk of Drug-Induced Liver Injury in Patients with COVID-19. Safety and Risk of Pharmacotherapy 2024; 12(3): 268 doi: 10.30895/2312-7821-2024-396
|